InsidersTradesSigma
Track the Gyrodyne, LLC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Real Estate sector, Gyrodyne, LLC has published 21 reports. Market capitalisation: €11.9m. The latest transaction was filed on 8 September 2025 (Cession). Among the most active insiders: TOWERVIEW LLC. The full history is openly available.
21
Insider Decl.
n/a
Thresholds
€28,181
3 ops.
Buy Volume
€476,581
7 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 September 2025
Declarations21 total
1,973 shares@ US$12.551.5% of flowCommon SharesSEC:0001166573-25-000005:0
8,698 shares@ US$8.000.63% mcap50.0% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001246739-25-000003:0
916 shares@ US$12.100.7% of flowCommon SharesSEC:0001166573-25-000004:0
1,216 shares@ US$12.100.9% of flowCommon SharesSEC:0001166573-25-000003:0
3,270 shares@ US$11.752.6% of flowCommon SharesSEC:0001166573-24-000009:0
4,368 shares@ US$7.99373.2% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001244352-24-000003:0
1,000 shares@ US$7.770.5% of flowCommon SharesSEC:0001166573-24-000007:0
Canonical exit: 7 Nov 2024 (T+90)
424 shares@ US$7.830.2% of flowCommon SharesSEC:0001166573-24-000005:0
Canonical exit: 30 Jul 2024 (T+90)
2,434 shares@ US$7.841.3% of flowCommon SharesSEC:0001166573-24-000004:0
Canonical exit: 15 Jul 2024 (T+90)
4,368 shares@ US$7.99373.2% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001244352-24-000002:0
9,690 shares@ US$8.0014.7% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001380362-24-000001:0
346 shares@ US$8.000.6% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001652934-24-000001:0
47,895 shares@ US$8.0034.0% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001244352-24-000001:0
8,672 shares@ US$8.0010.5% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001246739-24-000001:0
3,632 shares@ US$8.00100.0% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001437749-24-007862:0
177,541 shares@ US$8.0095.3% of flowCommon SharesSEC:0001166573-24-000003:0
20,362 shares@ US$21.6099.4% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001652934-23-000002:0
20,362 shares@ US$21.6085.3% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001380362-23-000003:0
30,542 shares@ US$21.6059.7% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001244352-23-000003:0
20,362 shares@ US$21.6068.3% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001246739-23-000002:0
30,000 shares@ US$13.04100.0% of flowCommon StockSEC:0001104659-21-111223:0
21 of 21 declarations
关于 Gyrodyne, LLC
Gyrodyne, LLC 是一家在美国纳斯达克上市的房地产公司，股票代码为 GYRO。对于讲法语的投资者而言，关键在于 Gyrodyne 并非一家拥有庞大全国性投资组合的综合性房地产投资信托基金 (REIT)；它是一个专注于从少数房产中提取价值的集中式、资产驱动型房地产平台。该公司以纽约有限责任公司的形式组建，总部位于纽约史密斯敦。其在长岛的运营历史超过 70 年，使其在该地区拥有长期的足迹，并对其核心子市场有着深入的了解。([gyrodyne.com](https://gyrodyne.com/?utm_source=openai)) Gyrodyne 目前的核心业务是拥有、运营和管理医疗办公和工业房地产投资组合，并致力于获取与这些资产相关的权利和开发权。该公司表示，其物业位于萨福克县的 Flowerfield 和威彻斯特县的 Cortlandt Manor，均在纽约州。它报告称，拥有并管理着超过 161,000 平方英尺的可租赁空间，分布在九座建筑物中，这表明其运营基础相对较小但重点突出。([sec.gov](https://www.sec.gov/Archives/edgar/data/1589061/000143774926010078/gyrllc20251231_10k.htm?utm_source=openai)) 从战略上讲，Gyrodyne 定位在一个利基医疗保健房地产领域，该领域历来受益于对医疗办公空间及相关用途的持久需求。该公司指出，它以前是一家上市公司 REIT，后来将其重点放在医疗保健相关的房地产上。其竞争优势不在于规模，而在于资产质量、选址和选择权：价值创造可能来自权利工作、再开发潜力以及土地和建筑物的最终货币化。这使得该名称更像是一个特殊情况，而非传统的物业运营商。([gyrodyne.com](https://gyrodyne.com/company_about.php?utm_source=openai)) 最近的发展强化了这种特殊情况的特征。在 2025 年年度报告中，Gyrodyne 表示其财务报表是按清算基础编制的，这表明其战略重心在于有序实现价值，而非长期投资组合扩张。该公司披露，截至 2025 年 12 月 31 日，剩余房地产的净可变现价值为 $53.99 million，同比增长主要受权利状态和市场条件驱动。2025 年 8 月，Gyrodyne 还强调了与开发相关的进展以及园区潜在的经济产出，而 2025 年的 SEC Form 4 文件显示了持续的内部人交易活动，市场参与者可能会密切关注。([sec.gov](https://www.sec.gov/Archives/edgar/data/0001589061/000143774926010078/gyrllc20251231_10k.htm?utm_source=openai)) 简而言之，Gyrodyne 是一家在美国纳斯达克上市的小盘美国房地产公司，最好理解为一个与纽约土地、医疗办公资产以及权利和再开发举措的成功相关的价值实现故事。
